Florbetaben f-18 clinical trials
Also written Neuraceq and Florbetaben.
How each study uses florbetaben f-18 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the florbetaben f-18 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 20 Feb 2014 · Neuraceq · EMEA/H/C/002553 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 7
Lantheus Biosciences Ltd. (4) · Lantheus Germany GmbH (2) · New York State Psychiatric Institute (1) · Sinotau Pharmaceutical Group (1) · Stanford University (1) · Ulsan University Hospital (1) · Molecular NeuroImaging (1) · Life Molecular Imaging SA (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses florbetaben f-18 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine ImagingNot yet recruitingNot applicableUniversity of ZurichNCT07624760Written as ¹⁸F-florbetaben
- Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy VolunteersCompletedPhase 2Lantheus Biosciences Ltd.NCT00750282Written as Florbetaben (BAY94-9172)
- Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to HistopathologyCompletedPhase 3Lantheus Biosciences Ltd.NCT01020838Written as Florbetaben (BAY94-9172)
- Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL AmyloidosisCompletedPhase 3Lantheus Germany GmbHNCT05184088Written as [18F]florbetaben
- Test-retest Study With [18F]FBB in Cardiac AmyloidosisCompletedPhase 1Lantheus Germany GmbHNCT06790394Written as Florbetaben F18
- Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With ADCompletedPhase 4Lantheus Biosciences Ltd.NCT02681172Written as Neuraceq (florbetaben 18F)
- Subjects With Subjective Cognitive Decline: 18F-Florbetaben Positron Emission Tomography StudyWithdrawnPhase 2Fundacion Clinic per a la Recerca BiomédicaNCT03057938Written as 18F-Florbetaben (FBB)
- Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CTTerminatedEarly Phase 1University of PennsylvaniaNCT04105634Written as Florbetaben
- Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172CompletedNot applicableNew York State Psychiatric InstituteNCT01222351Written as BAY 94-9172 (Florbetaben)
- A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese PopulationCompletedNot applicableSinotau Pharmaceutical GroupNCT05527288Written as Drug: [18F]florbetaben
- PET/MRI Evaluation of Cardiac AmyloidCompletedEarly Phase 1Stanford UniversityNCT03119558Written as 18F-Florbetaben (Neuraceq®) PET/MRI
- Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission TomographyCompletedNot applicableUlsan University HospitalNCT03779815Written as [18F]Florbetaben
- Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With TauopathiesCompletedEarly Phase 1Molecular NeuroImagingNCT02531360Written as [18F]MNI-815 (MNI-815)
- Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) PatientsCompletedPhase 1Lantheus Biosciences Ltd.NCT01138111Written as Florbetaben (BAY94-9172)
- Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.CompletedPhase 2Life Molecular Imaging SANCT00928304Written as Florbetaben (BAY94-9172)
Given beside what is tested · 1 — florbetaben f-18 is usual care or a partner of the new treatment
Codes
What other systems call florbetaben f-18 · ClinicalTrials.gg INT005250
- MeSH (NLM) C5277564-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbeneConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) TLA7312TOIFLORBETABEN F-18Confirmed FDA, NLM, Wikidata
- RxNorm 1492940Confirmed FDA, Wikidata
- Wikidata Q17014149florbetaben f-18Confirmed FDA, NLM, Wikidata
- DrugBank DB09148One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C527756 | 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | TLA7312TOI | FLORBETABEN F-18 | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1492940 | — | Confirmed FDA, Wikidata |
| Wikidata | Q17014149 | florbetaben f-18 | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB09148 | — | One source Wikidata |
Also registered as florbetaben (UNII BMO5G62HGB).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.